Literature DB >> 34376307

Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.

Kelsey L Lytle1, Sean P Collins1, Leora R Feldstein2, Adrienne H Baughman1, Samuel M Brown3, Jonathan D Casey1, Heidi L Erickson4, Matthew C Exline5, D Clark Files6, Kevin W Gibbs6, Adit A Ginde7, Michelle N Gong8, Carlos G Grijalva1, Akram Khan9, Christopher J Lindsell1, Ithan D Peltan3, Matthew E Prekker4, Todd W Rice1, Nathan I Shapiro10, Jay S Steingrub11, William B Stubblefield1, Mark W Tenforde2, Kelsey N Womack1, Manish M Patel2, Wesley H Self12.   

Abstract

INTRODUCTION: Understanding patient factors associated with not being vaccinated is essential for successful implementation of influenza vaccination programs.
METHODS: We enrolled adults hospitalized with severe acute respiratory illness at 10 United States (US) hospitals during the 2019-2020 influenza season. We interviewed patients to collect data about influenza vaccination, sociodemographic characteristics, and vaccine perceptions.
RESULTS: Among 679 participants, 264 (38.9%) reported not receiving influenza vaccination. Among those not vaccinated, 135 (51.1%) reported choosing not to receive a vaccine because of perceived ineffectiveness (36.7%) or risk (14.4%) of influenza vaccination. Sociodemographic factors associated with not being vaccinated included no medical insurance (aOR = 6.42; 95% CI: 2.52-16.38) and being non-White or Hispanic (aOR = 1.54, 95% CI: 1.02-2.32).
CONCLUSIONS: Optimizing uptake of influenza vaccination in the US may be improved by educational programs regarding vaccine safety and effectiveness and enhancing vaccine access, particularly among non-White and Hispanic Americans and those without medical insurance.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Influenza; Medical insurance; Vaccination; Vaccine acceptance; Vaccine hesitancy

Mesh:

Substances:

Year:  2021        PMID: 34376307      PMCID: PMC8588478          DOI: 10.1016/j.vaccine.2021.07.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  12 in total

1.  Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018.

Authors:  Chelsea S Lutz; Rebecca V Fink; Ann J Cloud; John Stevenson; David Kim; Amy Parker Fiebelkorn
Journal:  Vaccine       Date:  2019-12-27       Impact factor: 3.641

2.  Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden in the United States.

Authors:  Michelle M Hughes; Carrie Reed; Brendan Flannery; Shikha Garg; James A Singleton; Alicia M Fry; Melissa A Rolfes
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

3.  Using implementation intentions prompts to enhance influenza vaccination rates.

Authors:  Katherine L Milkman; John Beshears; James J Choi; David Laibson; Brigitte C Madrian
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 12.779

4.  Reasons given for not receiving an influenza vaccination, 2011-12 influenza season, United States.

Authors:  Tammy A Santibanez; Erin D Kennedy
Journal:  Vaccine       Date:  2016-04-24       Impact factor: 3.641

5.  Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.

Authors:  Carlos G Grijalva; Leora R Feldstein; H Keipp Talbot; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Jonathan D Casey; Heidi L Erickson; Matthew C Exline; D Clark Files; Kevin W Gibbs; Adit A Ginde; Michelle N Gong; Natasha Halasa; Akram Khan; Christopher J Lindsell; Samuel K Nwosu; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay S Steingrub; William B Stubblefield; Mark W Tenforde; Manish M Patel; Wesley H Self
Journal:  Clin Infect Dis       Date:  2021-10-20       Impact factor: 9.079

6.  Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.

Authors:  Louise A Brown Nicholls; Allyson J Gallant; Nicola Cogan; Susan Rasmussen; David Young; Lynn Williams
Journal:  Vaccine       Date:  2021-05-20       Impact factor: 3.641

Review 7.  Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.

Authors:  Philipp Schmid; Dorothee Rauber; Cornelia Betsch; Gianni Lidolt; Marie-Luisa Denker
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 8.  The Burden of Influenza: a Complex Problem.

Authors:  Aubree Gordon; Arthur Reingold
Journal:  Curr Epidemiol Rep       Date:  2018-02-05

9.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Authors:  Lisa A Grohskopf; Elif Alyanak; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2019-08-23

10.  Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.

Authors:  Wesley H Self; Mark W Tenforde; William B Stubblefield; Leora R Feldstein; Jay S Steingrub; Nathan I Shapiro; Adit A Ginde; Matthew E Prekker; Samuel M Brown; Ithan D Peltan; Michelle N Gong; Michael S Aboodi; Akram Khan; Matthew C Exline; D Clark Files; Kevin W Gibbs; Christopher J Lindsell; Todd W Rice; Ian D Jones; Natasha Halasa; H Keipp Talbot; Carlos G Grijalva; Jonathan D Casey; David N Hager; Nida Qadir; Daniel J Henning; Melissa M Coughlin; Jarad Schiffer; Vera Semenova; Han Li; Natalie J Thornburg; Manish M Patel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-04       Impact factor: 17.586

View more
  2 in total

1.  Explorative study regarding influenza vaccine hesitancy among HIV-infected patients.

Authors:  Valentina Marchese; Samuele Storti; Claudia Morganti; Giorgio Tiecco; Melania Degli Antoni; Emanuele Focà; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Hum Vaccin Immunother       Date:  2022-03-31       Impact factor: 4.526

2.  Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes.

Authors:  Michael J Ward; David J Douin; Wu Gong; Adit A Ginde; Catherine L Hough; Matthew C Exline; Mark W Tenforde; William B Stubblefield; Jay S Steingrub; Matthew E Prekker; Akram Khan; D Clark Files; Kevin W Gibbs; Todd W Rice; Jonathan D Casey; Daniel J Henning; Jennifer G Wilson; Samuel M Brown; Manish M Patel; Wesley H Self; Christopher J Lindsell
Journal:  J Clin Transl Sci       Date:  2022-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.